September 29, 2016 3:19 AM ET

Pharmaceuticals

Company Overview of Omthera Pharmaceuticals, Inc.

Key Executives for Omthera Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Stephen F. Mohr 6 RelationshipsChairman and President--
Michael H. Davidson M.D., Facc., Facp.91 RelationshipsCo-Founder and Chief Medical Officer59
Mark S. Uhle No RelationshipsChief Financial Officer and Vice President of Finance--
Douglas Carr No RelationshipsFinancial Controller--
Bharat M. Mehta Ph.D.No RelationshipsVice President of CMC/Manufacturing--

Omthera Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Stephen F. Mohr 6 RelationshipsOmthera Pharmaceuticals, Inc.--
Daniel J. Rader M.D., FAHA 50 RelationshipsVascular Strategies LLC--
Johannes Jacob Pieter Kastelein M.D., Ph.D., FESC 107 RelationshipsAtheroNova Inc.62
David G. Orloff M.D. 37 RelationshipsDiasome Pharmaceuticals, Inc.--
Kevin C. Maki Ph.D. 28 RelationshipsMatinas BioPharma Holdings, Inc.--
View All Board Members

Omthera Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., FAHADaniel J. Rader50 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
404.7K
Bonus
511.4K
Total Short Term Compensation
593.0K
Total Value of Options
14.4M
Compensation as of Fiscal Year
Omthera Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Cornelia (Cori) Bargmann to Step Down as Non-Executive Director of AstraZeneca, Effective October 1, 2016
September 28, 2016 6:00 AM ET
Abattis Bioceuticals Corp. Appoints Shuang Xie as Newest Science and Technology Advisor
September 27, 2016 8:20 PM ET
Kitov Pharmaceuticals Holdings Ltd. Announces Resignation of Moran Sherf Blau from the Board of Directors and all Board Committees
September 27, 2016 1:29 PM ET
Imprimis Pharmaceuticals, Inc. Announces the Resignation of William H. Nelson as Independent Director and from All Board Committee Positions, Effective Immediately
September 26, 2016 9:00 PM ET
The Fonds de solidarité FTQ, CTI Life Sciences Fund and Servier Canada Announce Creation of ILKOS THERAPEUTICS Inc.; Announces Board Appointments
September 26, 2016 5:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Omthera Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.